LIAONING CHENG DA BIOTECHNOLOGY revenue breakdown overview

LIAONING CHENG DA BIOTECHNOLOGY revenue for the last year amounted to 1.75 B CNY, the most of which — 1.64 B CNY — came from its highest performing source at the moment, Human Rabies Vaccine, the year earlier bringing 1.77 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought LIAONING CHENG DA BIOTECHNOLOGY 1.62 B CNY, and the year before that — 1.68 B CNY.